glp-1 testosterone Replacement Therapy as a Potential Strategy to Preserve Lean Mass in Men With Persistently Low Serum Testosterone Receiving Receptor Agonists: A Narrative Review Multiple new studies have found

also indicated that, compared to other antidiabetic drugs, DPP-4 inhibitors led to an increased number of reports of gallbladder or biliary diseases, with sitagliptin accounting for up to 80% of the cases ( For GLP-1 RAs, our results indicated that although it did not show a direct correlation with biliary diseases overall, specific drugs such as semaglutide [ROR 4.06

The microdose tirzepatide maintenance approach is something some people use successfully at lower ongoing doses

Indications and mechanism of action As described by Liu, GLP-1 pathophysiology involves multiple mechanisms of action that improve glucose control and promote weight loss, including enhanced insulin secretion, inhibited glucagon release, delayed gastric emptying, increased satiety, and improved insulin sensitivity

Additionally, keeping blood sugar stable reduces the risk of complications such as heart disease, which is more common for people with psoriatic arthritis and diabetes

SGLT2 inhibitors (such as dapagliflozin or empagliflozin), often co-prescribed with GLP-1 agonists for diabetes management, work by increasing glucose excretion in urine, which increases urinary frequency as an expected and common pharmacological effect